Impact of Combination Therapy with Amlodipine and Atorvastatin on Plasma Adiponectin Levels in Hypertensive Patients with Coronary Artery Disease: Combination Therapy and Adiponectin

References

• . Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A. Vascular effects of adiponectin: Molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond). 2008; 114(5):361–374
   PubMed Web of Science ®Google Scholar
• . Arita Y, Kihara S, Ouchi N, . Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002; 105(24):2893–2898
   PubMed Web of Science ®Google Scholar
• . Lam KS, Xu A. Adiponectin: Protection of the endothelium. Curr Diab Rep. 2005; 5(4):254–259
   PubMedGoogle Scholar
• . Hotta K, Funahashi T, Arita Y, . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20(6):1595–1599
   PubMed Web of Science ®Google Scholar
• . Matsuzawa Y. Therapy insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006; 3(1):35–42
   PubMedGoogle Scholar
• . Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: A key adipocytokine in metabolic syndrome. Clin Sci (Lond). 2006; 110(3):267–278
   PubMed Web of Science ®Google Scholar
• . Chow WS, Cheung BM, Tso AW, . Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension. 2007; 49(6):1455–1461
   PubMed Web of Science ®Google Scholar
• . Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003; 16(1):72–75
   PubMed Web of Science ®Google Scholar
• . Iwashima Y, Katsuya T, Ishikawa K, . Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004; 43(6): 1318–1323
   PubMed Web of Science ®Google Scholar
• . Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 2002; 87(6):2764–2769
   PubMed Web of Science ®Google Scholar
• . Kazumi T, Kawaguchi A, Hirano T, Yoshino G. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism. 2004; 53(5):589–593
   PubMed Web of Science ®Google Scholar
• . Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004; 27(7):1680–1687
   PubMed Web of Science ®Google Scholar
• . McKeage K, Siddiqui MA. Amlodipine/atorvastatin fixed-dose combination: A review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia. Am J Cardiovasc Drugs. 2008; 8(1):51–67
   PubMed Web of Science ®Google Scholar
• . Erdine S, Ro YM, Tse HF, . Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study). J Hum Hypertens. 2009; 23(3):196–210
   PubMed Web of Science ®Google Scholar
• . Sever PS, Dahlof B, Poulter NR, ; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 2003; 361(9364):1149–1158
   PubMed Web of Science ®Google Scholar
• . Dahlöf B, Sever PS, Poulter NR, ; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005; 366(9489):895–906
   PubMed Web of Science ®Google Scholar
• . Xu A, Chan KW, Hoo RL, . Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005; 280(18):18073–18080
   PubMed Web of Science ®Google Scholar
• . Wong CY, Qiuwaxi J, Chen H, . Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes. Mol Nutr Food Res. 2008; 52(12):1421–1427
   PubMed Web of Science ®Google Scholar
• . Hu R, Siu CW, Lau EO, Wang WQ, Lau CP, Tse HF. Impaired nitrate-mediated dilatation could reflect nitrate tolerance in patients with coronary artery disease. Int J Cardiol. 2007; 120(3):351–356
   PubMed Web of Science ®Google Scholar
• . Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39(2):175–191
   PubMed Web of Science ®Google Scholar
• . Cowie MR. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: Focus on amlodipine/atorvastatin single-pill therapy. Int J Clin Pract. 2005; 59(7):839–846
   PubMed Web of Science ®Google Scholar
• . Chobanian AV, Bakris GL, Black HR, ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206–1252
   PubMed Web of Science ®Google Scholar
• . Jukema JW, van der Hoorn JW. Amlodipine and atorvastatin in atherosclerosis: A review of the potential of combination therapy. Expert Opin Pharmacother. 2004; 5(2):459–468
   PubMed Web of Science ®Google Scholar
• . Lam KS, Xu A, Tan KC, Wong LC, Tiu SC, Tam S. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab. 2004; 89(11):5448–5453
   PubMed Web of Science ®Google Scholar
• . Koh KK, Quon MJ, Han SH, . Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension. Int J Cardiol. 2011; 146(3):319–325
   PubMed Web of Science ®Google Scholar
• . Corretti MC, Anderson TJ, Benjamin EJ, ; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 39(2):257–265
   PubMed Web of Science ®Google Scholar
• . Li R, Wang WQ, Zhang H, . Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am J Physiol Endocrinol Metab. 2007; 293:E1703–E1708
   PubMed Web of Science ®Google Scholar
• . Cheung BM, Kumana CR. Natriuretic peptides—relevance in cardiovascular disease. JAMA. 1998; 280(16):1983–1984
   PubMedGoogle Scholar